New SNCA mutation and structures of α-synuclein filaments from juvenile-onset synucleinopathy

Yang Yang, Holly J. Garringer, Sofia Lövestam, Xianjun Zhang, Abhay Kotecha, Mehtap Bacioglu, Atsuo Koto, Masaki Takao, Maria Grazia Spillantini, Bernardino Ghetti, Rubén Vidal, Alexey G. Murzin, Sjors H. W. Scheres, Michel GoedertbioRxiv 2022 · DOI

TL;DR

Researchers have identified a novel mutation in the SNCA gene associated with a rare, early-onset neurodegenerative disease. Using cryo-electron microscopy, they determined the atomic structures of the resulting α-synuclein filaments, revealing a unique fold distinct from those found in Parkinson's disease and multiple system atrophy, offering new insights into synucleinopathies.

What Problem Does This Paper Address?

Synucleinopathies, a group of neurodegenerative diseases including Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA), are characterized by the aggregation of α-synuclein protein into filamentous inclusions in the brain. While different synucleinopathies are associated with distinct α-synuclein fibril structures (folds), the underlying genetic causes and the structural variations in rare, early-onset forms of these diseases are not fully understood. This paper investigates a unique case of juvenile-onset synucleinopathy (JOS) with an unusual genetic mutation and aims to elucidate the structure of the α-synuclein filaments formed in this condition.

Methods

The study employed a multi-pronged approach:

  • Genetic Analysis: DNA sequencing was used to identify mutations in the SNCA gene in the JOS patient.
  • Biochemical Extraction: Sarkosyl-insoluble material, enriched in aggregated proteins, was extracted from the frontal cortex of the JOS patient.
  • Cryo-Electron Microscopy (Cryo-EM): This high-resolution imaging technique was used to determine the three-dimensional structures of the α-synuclein filaments extracted from the JOS brain. Specifically, the researchers used advanced techniques for helical reconstruction and model building.
  • Immunoblotting: This technique was used to detect and compare the presence of wild-type and mutant α-synuclein in the extracted material.
  • Immunohistochemistry and Silver Staining: These methods were used to visualize α-synuclein inclusions and assess neuronal pathology in brain tissue.

Datasets

The primary dataset used in this study was derived from the frontal cortex tissue of a single individual diagnosed with juvenile-onset synucleinopathy (JOS). This tissue was analyzed using the methods described above. No external datasets were used for training or evaluation in the context of machine learning.

Key Insights and Ideas

  • A Novel SNCA Mutation: The identification of a 21-nucleotide duplication in the SNCA gene, leading to a seven-amino acid insertion (MAAAEKT) in α-synuclein, is a significant discovery. This mutation appears to be the first reported duplication mutation in SNCA and is likely de novo, as the parents were unaffected.
  • A New α-Synuclein Fold: The cryo-EM structural analysis revealed a novel α-synuclein fold, termed the "JOS fold," which is distinct from the previously characterized Lewy body and MSA folds. This highlights the structural diversity of α-synuclein aggregates and their potential to cause different disease phenotypes.
  • Structural Similarities to MSA: Despite being a new fold, the JOS fold shares some structural similarities with MSA filaments, particularly in its core substructure and the arrangement of its "islands," suggesting potential commonalities in cofactor binding and fibril formation mechanisms.
  • Mixed Wild-Type and Mutant Filaments: The study confirmed the presence of both wild-type and mutant α-synuclein within the JOS filaments, suggesting a cooperative mechanism where the mutant protein might nucleate fibril formation, followed by the incorporation of wild-type protein during elongation.
  • Cofactor Involvement: The presence of a non-proteinaceous cofactor bound within the JOS fold, similar to observations in other synucleinopathies, points to the crucial role of cofactors in modulating α-synuclein aggregation and fibril structure.

Key Results

  • Genetic Finding: A 21-nucleotide duplication in SNCA was identified in the JOS patient, resulting in a 147-amino acid mutant α-synuclein.
  • Structural Determination: The cryo-EM analysis yielded high-resolution structures of JOS filaments:
  • Singlet filaments (83% of observed filaments) at 2.0 Å resolution.
  • Doublet filaments (17% of observed filaments) at 2.3 Å resolution.
  • JOS Fold Characteristics: The JOS fold comprises a compact core (residues 36-100) and two disconnected density islands (A and B), with a bound cofactor between the core and island A.
  • Neuropathology: The JOS case exhibited abundant α-synuclein inclusions, prominent gliosis, and severe neuronal loss, consistent with a severe synucleinopathy.

Limitations and Future Work

  • Single Case Study: The findings are based on a single JOS case, which limits the generalizability of the mutation's impact and the observed fibril structure. Future studies with additional JOS cases would be valuable.
  • Sequence Assignment in Islands: While the core structure was well-resolved, the precise sequence composition of the "islands" (A and B) within the JOS fold was challenging to assign definitively due to less resolved side-chain densities.
  • Mechanism of Fibrillation: The proposed mechanism of mutant α-synuclein nucleating fibril formation and wild-type protein elongating it is a likely model, but further experimental validation would strengthen this hypothesis.
  • Cofactor Identity: The exact identity of the non-proteinaceous cofactor remains unknown and warrants further investigation.
  • Therapeutic Implications: Understanding the structural differences between JOS, Lewy body, and MSA folds could pave the way for developing more targeted therapeutic strategies for different synucleinopathies. Future work could focus on how these distinct structures interact with cellular components or therapeutic agents.

Summary updated

Abstract

ABSTRACT A 21-nucleotide duplication in one allele of SNCA was identified in a previously described disease with abundant α-synuclein inclusions that we now call juvenile-onset synucleinopathy (JOS). Both wild-type α-synuclein and its insertion mutant containing seven additional residues (MAAAEKT) after residue 22 were present in sarkosyl-insoluble material that was extracted from frontal cortex of the individual with JOS and examined by electron cryo-microscopy. The structures of JOS filaments, comprising either a single protofilament, or a pair of protofilaments, revealed a new α-synuclein fold that differs from the folds of Lewy body diseases and multiple system atrophy (MSA). The JOS fold consists of a compact core, the sequence of which (residues 36-100 of wild-type α-synuclein) is unaffected by the mutation, and two disconnected density islands (A and B) of mixed sequences. There is a non-proteinaceous cofactor bound between the core and island A. The JOS fold resembles the common substructure of MSA type I and type II dimeric filaments, with its core segment approximating the C-terminal body of MSA protofilaments B and its islands mimicking the N-terminal arm of MSA protofilaments A. The partial similarity of JOS and MSA folds extends to the locations of their cofactor-binding sites. Our findings provide insight into a likely mechanism of JOS fibrillation in which mutant α-synuclein of 147 amino acids forms a nucleus with the JOS fold, around which wild-type and mutant proteins assemble during elongation.
BibTeX
@misc{yang2022new,
  author = {Yang Yang and Holly J. Garringer and Yue‐De Yang and Sofia Lövestam and Xianjun Zhang and Abhay Kotecha and Mehtap Bacioglu and Atsuo Koto and Masaki Takao and Maria Grazia Spillantini and Bernardino Ghetti and Rubén Vidal and Alexey G. Murzin and Sjors H. W. Scheres and Michel Goedert},
  title = {{New <i>SNCA</i> mutation and structures of α-synuclein filaments from juvenile-onset synucleinopathy}},
  year = {2022},
  doi = {10.1101/2022.11.23.517690},
  howpublished = {bioRxiv},
}
Figure